The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| DGX | +15.9% | +53.43% | +8.93% | +6,952% |
| S&P | +13.35% | +91.49% | +13.87% | +826% |
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.82B | 13.2% |
| Gross Profit | $911.00M | 16.2% |
| Gross Margin | 32.35% | 0.8% |
| Market Cap | $21.31B | 23.3% |
| Market Cap / Employee | $0.38M | 0.0% |
| Employees | 56K | 16.7% |
| Net Income | $257.00M | 8.9% |
| EBITDA | $562.00M | 18.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $432.00M | -43.5% |
| Accounts Receivable | $1.46B | 5.8% |
| Inventory | 186 | 1.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $5.71B | -7.9% |
| Short Term Debt | $677.00M | -13.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.96% | 0.3% |
| Return On Invested Capital | 10.83% | -0.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $419.00M | 67.6% |
| Operating Free Cash Flow | $563.00M | 58.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 19.60 | 21.39 | 21.48 | 22.36 | 7.30% |
| Price to Book | 2.48 | 2.77 | 2.90 | 2.95 | 13.39% |
| Price to Sales | 1.73 | 1.88 | 1.93 | 1.98 | 7.92% |
| Price to Tangible Book Value | -4.81 | -4.89 | -5.52 | -6.35 | -8.97% |
| Price to Free Cash Flow TTM | 29.49 | 26.55 | 23.01 | 20.59 | -18.32% |
| Enterprise Value to EBITDA | 46.25 | 50.52 | 46.62 | 49.12 | -2.22% |
| Free Cash Flow Yield | 3.4% | 3.8% | 4.3% | 4.9% | 22.43% |
| Return on Equity | 13.2% | 13.4% | 13.7% | 13.7% | 8.11% |
| Total Debt | $6.93B | $6.57B | $6.38B | $6.38B | -8.44% |
No podcast episodes available.
DGX earnings call for the period ending September 30, 2021.
DGX earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
